跳至主要内容
临床试验/NCT00572338
NCT00572338已完成不适用

UARK 91-004 Therapeutic Research in Multiple Myeloma

University of Arkansas1 个研究点 分布在 1 个国家目标入组 6,388 人开始时间: 2003年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
6,388
试验地点
1

研究概览

简要总结

The purpose of this study is to learn how myeloma cells grow and become a cancer, how to distinguish them from normal cells and how to eliminate these cells selectively.

详细描述

Participating in this study will require that blood and bone marrow samples be obtained as a part of the diagnostic work-up or follow-up of your multiple myeloma. Bone marrow/peripheral blood/tissue samples will be collected for research purposes, as well as testing for genetic traits of Castleman's disease if you consent to this study. In addition, data will be collected including demographic information gathered from your medical record, including gender, date of birth, ethnicity, date of diagnosis, laboratory and pathology results, treatment protocols, dates of relapses, subsequent treatment protocols, and current treatments and medications.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Any subject evaluated for a MIRT protocol

排除标准

  • Subjects who have not been evaluated for a MIRT protocol

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验